BeOne Medicines (BEIGF) Cash from Operations Growth (1y) (2016 - 2026)
BeOne Medicines (BEIGF) Cash from Operations Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
356.73% |
| Date | Value |
|---|
| Mar 31, 2026 |
356.73% |
| Dec 31, 2025 |
455.28% |
| Sep 30, 2025 |
113.70% |
| Jun 30, 2025 |
375.76% |
| Mar 31, 2025 |
114.29% |
| Dec 31, 2024 |
133.91% |
| Sep 30, 2024 |
341.04% |
| Jun 30, 2024 |
67.47% |
| Mar 31, 2024 |
45.27% |
| Dec 31, 2023 |
30.34% |
| Sep 30, 2023 |
86.09% |
| Jun 30, 2023 |
22.65% |
| Mar 31, 2023 |
-138.32% |
| Dec 31, 2022 |
-350.36% |
| Sep 30, 2022 |
-13.35% |
| Jun 30, 2022 |
9.59% |
| Mar 31, 2022 |
-289.11% |
| Dec 31, 2021 |
138.24% |
| Sep 30, 2021 |
-43.17% |
| Jun 30, 2021 |
-59.83% |
